NCT06533657 2026-03-12
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2 Active not recruiting
Clinical Trials
20 trialsNCT05265052 2026-03-11
3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain
3D Medicines
Phase 2 Not yet recruiting
NCT06728579 2025-12-22
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT04095234 2025-10-10
Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT05877521 2025-09-23
Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT06663956 2025-07-24
A Randomized Controlled Trial of a Web-based Platform for Cancer Pain Management
West China Hospital
Phase 2 Recruiting
NCT05328973 2024-12-02
Intraoperative Aromatherapy Versus Placebo for Port-a-Cath Placement Under Monitored Anesthesia Care. A Randomized Controlled Trial
M.D. Anderson Cancer Center
Phase 2 Completed
NCT05067257 2024-03-18
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
Sorrento Therapeutics, Inc.
Phase 2 Suspended
NCT04666623 2023-10-19
IMPORTANCE
University Hospital, Basel, Switzerland
Phase 2 Withdrawn
NCT05800834 2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
NCT05299047 2022-08-16
Fluoroscopic Anterior Approach Versus Ultrasound Guided Superior Hypogastric Plexus Neurolysis in Cancer Pelvic Pain
Mansoura University
Phase 2 Unknown
NCT03362073 2021-09-28
CIVIK
Pusan National University Yangsan Hospital
Phase 2 Unknown
NCT04042545 2021-09-16
PLENITUDE
Tetra Bio-Pharma
Phase 2 Unknown
NCT00830180 2021-04-05
Open Label Extension In Cancer Patients
Pfizer
Phase 2 Completed
NCT04243954 2021-03-05
Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration
Fujian Cancer Hospital
Phase 2 Completed
NCT00431639 2019-04-11
Effects of Pet Therapy on Pain in Cancer Patients
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00929188 2016-01-22
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Janssen Research & Development, LLC
Phase 2 Completed
NCT01931865 2015-12-31
IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Yale University
Phase 2 Terminated
NCT00684242 2013-01-28
Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00216658 2011-01-24
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
Janssen Pharmaceutical K.K.
Phase 2 Completed